Pharnext Company
Pharnext is a biopharmaceutical company engaged in the development of treatments for severe neurological diseases.
Headquarters:
Issy-les-moulineaux, Ile-de-France, France
Total Funding:
157576441.0
Founded Date:
2007-04-01
Employee Number:
11-50
Last Funding Type:
Post-IPO Equity
Investors Number:
4.0
Last Funding Date:
2021-06-07
Technology:
Biopharma, Biotechnology, Medical, Neuroscience, Pharmaceutical
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Industry:
Neurodegenerative disease diagnosis and treatment